Main article: Artificial lung ventilation devices (IVL)
2020
Dassault Systèmes helped Indian startup Inali develop an intelligent ventilator in 8 days
On April 1, 2020, it became known that as part of initiatives aimed at promptly solving emergency requests in a pandemic, COVID-19 Dassault Systemes 3DExperience the Lab laboratory supported to Indian to startup Inali and helped to develop a safe and affordable intelligent ventilator in a short time. More. here
Philips introduced a new ventilator and promised to produce 15 thousand units per week
In mid-April 2020, Royal Philips introduced the new Philips Responics E30 ventilator, a universal device designed for non-invasive and invasive ventilation of patients with coronavirus infection, and promised to produce 15,000 units a week to combat the pandemic. Read more here.
Boston Scientific begins mass production of ventilators for $1,000
In mid-April 2020, Boston Scientific announced its readiness to begin production of inexpensive ventilators. The company remains to wait for the permission of US regulators, but due to the COVID-19 coronavirus pandemic, the deadlines will not be delayed. Read more here.
New York pays 15 times the normal cost for medical equipment
In early April 2020, it became known that New York State is forced to pay 15 times the usual cost for medical equipment and consumables. A shortage of medicines forced New York to enter into bidding with other states for ventilators and personal protective equipment, which led to price gouging. Read more here.
The American Ministry of Health buys 73 thousand ventilators from GM and Philips for $1 billion
On April 8, 2020, the US Department of Health and Human Services (HHS) announced the conclusion of two contracts with a total value of more than $1 billion for the production of artificial lung ventilation devices that are necessary for seriously ill patients with the COVID-19 coronavirus. Read more here.
Xerox began mass production of ventilators
In early April 2020, Xerox and Vortran Medical Technology announced a collaboration in which the companies plan to launch the production of Vortran GO2Vent emergency breathing support devices and the corresponding APM-Plus airway pressure monitor. Read more here.
Mask's free ventilators turned out to be useless for seriously ill patients with COVID-19
In early April 2020, it became known that free ventilators, donated Elon Musk To Los Angeles and, turned out To New York to be useless for seriously ill patients with. COVID-19 Judging by the photo taken in one of the hospitals, the devices acquired by Musk are not at all IVL systems - these are just BPAP, two-phase ventilation devices with positive pressure in the respiratory tract. They are used to treat sleep apnea by maintaining constant breathing at night.
Although BPAP devices are sometimes called "non-invasive ventilation," they are far from ventilators that can be used in intensive care units. Ventilators are invasive ventilators that deliver oxygen to the lungs and are used as part of a life support system. It is the invasive means of ventilation that most of the world so desperately needs. BPAP devices are much more common: according to Forbes, more than 8 million people use them in the United States alone. In the end, they cost only $800, while ventilators are about $50,000, that is, 60 times more.
Although the researchers are looking for ways in which BPAP machines can be rebuilt to help patients with Covid-19, these devices still cannot be used in severe cases that require intensive care. In addition, the American Society of Anesthesiologists in February issued a warning that BPAP devices "may increase the risk of transmission."
Elon Musk continues to offer hospitals help, insisting that all his devices are "approved by regulatory authorities." He did not lie directly, because the FDA issued a notification, allowing hospitals in an emergency in case of a shortage of ventilators to use alternative devices. These alternative facilities included BPAP sets.[1]
The United States signed a contract with four medical tech companies for the supply of 8 thousand ventilators
At the end of March 2020, the US Defense Logistics Agency, part of the US Department of Defense (Pentagon), signed a $84.4 million contract with four medical companies to produce 8,000 ventilators to combat the COVID-19 pandemic. Read more here.
Tesla restarts New York plant to produce Medtronic ventilators
At the end of March 2020, Tesla announced that it would restart the New York plant, which previously produced solar panels. Now it will launch the production of artificial lung ventilation devices developed by Medtronic. Read more here.
Medtronic doubles production of ventilators to fight coronavirus
In mid-March 2020, several manufacturers of medical equipment in the United States announced an increase in artificial lung ventilation devices to combat the COVID-19 coronavirus. So, in response to reports of a shortage of such devices, Medtronic announced that it was going to double the production and supply of ventilators. Read more here.
In Spain, they begin to print ventilation devices on 3D printers
At the end of March 2020, Consorci de la Zona Franca, HP Inc., Leitat and CatSalut developed the first 3D printing device for emergency ventilation, which is intended for industrial production. The device is a valve mask that can be used for short-term emergency ventilation of patients with COVID-19. Read more here.
Vacuum cleaner manufacturer Dyson decided to produce ventilators
At the end of March 2020, Dyson announced that the company would produce ventilators. The vacuum cleaner manufacturer announced this after the British authorities called on business to provide local health authorities with the necessary equipment to combat the Covid-19 coronavirus. Read more here.
2015: $638.7 million market size - Research and Markets data
On March 15, 2017, the analytical company Research and Markets announced some results of a study of the market for artificial ventilation devices.
Sales of such equipment in 2015 reached $638.7 million globally. This market is expected to grow by an average of 7.7% annually between now and 2022, the report said.
According to experts, the main factors in the growth of demand for ventilators are an increase in the number of respiratory diseases and the share of the aging population, rapid urbanization and environmental pollution, as well as lifestyle changes and the widespread prevalence of tobacco smoking.
The potential for strong growth in developing countries and the growing demand for therapeutic devices for home care are key opportunities for further development of the market in question.
However, there are many restraining factors: weak development of benefits in terms of the use and purchase of artificial ventilation devices, complications when using such devices, insufficient awareness of medical institutions about the capabilities of equipment and the negative consequences of using several devices for newborns.
The fastest growing segment of the ventilator market, according to Research and Markets, will be portable solutions, facilitated by an increase in the number of elderly people on the planet and growing sales of home care equipment. Between 2016 and 2022, sales of devices used for home care are expected to increase by an average of 8.4% per year.[2]
The following companies are called the largest manufacturers of artificial lung ventilation devices by analysts:
- ResMed;
- GE Healthcare;
- Hamilton Medical;
- Philips Healthcare;
- Becton, Dickinson and Company;
- Medtronic.
Artificial lung ventilation devices (Russian market)
Main article: Artificial lung ventilation devices (Russian market)
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |